Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ezetrol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
AIMS Hypolipidemic drugs are prescribed in the most of cases for the treatment of cardiovascular diseases. Several studies have… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
OBJECTIVES To assess the lipid-lowering efficacy of ezetimibe in dyslipidemic cynomolgus monkeys comparing two dosing methods… Expand
Is this relevant?
2012
2012
The aim of this study was to investigate the bioavailability enhancement of the biopharmaceutics classification system class II… Expand
Is this relevant?
Review
2011
Review
2011
Ezetimibe (Zetia(®), Ezetrol(®), Merck, Whitehouse Station, NJ) is a potent inhibitor of sterol absorption, which selectively… Expand
Is this relevant?
2011
2011
Ezetimibe is a drug that lowers cholesterol. It acts by decreasing cholesterol absorption in the intestine. It may be used alone… Expand
Is this relevant?
2009
2009
L'ezetimibe *(Ezetrol ® ) inhibe selectivement l'absorption intestinale du cholesterol et des phytosterols apparentes. Son… Expand
Is this relevant?
Review
2009
Review
2009
  • Drug and Therapeutics Bulletin
  • 2009
  • Corpus ID: 868066
▼Ezetimibe (Ezetrol – MSD-Schering Plough) is a lipid-lowering drug that reduces plasma concentrations of low-density lipoprotein… Expand
Is this relevant?
2006
2006
Ezetimibe (Ezetrol) is a novel cholesterol lowering drug which disposition is not fully understood in man. We developed a… Expand
Is this relevant?
2006
2006
BACKGROUND For patients who have above-target low-density lipoprotein cholesterol (LDL-C) levels while on statin monotherapy… Expand
Is this relevant?
2003
2003
Ezetrol® (Ezetimibe) is the first substance of a new class of selective cholesterol absorption inhibitors; it was registered in… Expand
Is this relevant?